Clinical Trial Update: Dysbindin-antipsychotics Psychophamarcogenetics: a Mouse-human Translational Study Towards Personalized Healthcare in Bipolar Disorders

View source ↗

Summary

A completed translational clinical trial investigating dysbindin-associated pharmacogenetics to tailor antipsychotic treatment for bipolar disorder, integrating…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Snippet

Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Conditions: Bipolar Disorder | Status: COMPLETED